Josh Gottheimer sold NVZMY (Novozymes A/S) on Jun 1, 2026 with an estimated value between $1,000 and $15,000. This trade was filed under undisclosed. This trade has been flagged by Watchdog. Josh Gottheimer serves on the House Committee on Financial Services.
Stay ahead of trades like this
Josh Gottheimer traded NVZMY in their committee’s jurisdiction. Create a free account to explore Watchdog analysis.
Free forever. Upgrade anytime.